December 2014: As reported in Business Insider, M.H. Carnegie & Co. is pursuing a “reverse brain drain” strategy through its medical technology investments.
Carnegie is buying innovative medical companies in America and turning them into Australian outfits that benefit from generous tax breaks for research and development. Simplify Medical is the latest of these investments.